Clinical Trial

Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 4, 2022 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Oral potentially malignant disorders (OPMDs) are chronic pathologies which can suffer dysplastic alterations and evolve into oral cancer. The diagnosis of those pathologies is commonly done by visual inspection, which is not capable of determining the presence or not of dysplasia. Furthermore, this type of diagnosis depends greatly on the expertise and training of the professional. In recent years, new methods that can help early oral cancer diagnosis have been developed. A new device has been commercialized, named GOCCLES® (Glasses for Oral Cancer Curing Light Exposed Screening), based on the autofluorescence principle. The hypothesis of this study is that GOCCLES® device could be an effective tool to help in early detection of oral cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-27.
Trial Details
NCT Number NCT05562375
Lead Sponsor Universidad Rey Juan Carlos
Conditions Oral Potentially Malignant Disorders, Oral Cancer
Enrollment 73 participants
Start Date 2022-01-08
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2022-10-04